Fundraising FoxK2 HealthVentures — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Evergreen Nephrology partners with nephrologists to manage kidney care for patients with kidney disease, focusing on outcomes such as preventing hospitalizations, slowing disease progression, and increasing transplant rates.
Digital HealthHealthtechNashville, US
Matt Kim(Director)Arjun Aggarwal(Director)Scott Lloyd(Executive Officer)Abe Sutton(Director)Eric Jenkins(Executive Officer)
BoardAdam Boehler(Director)
Co-investorsHealth2047 Capital Partners LLCMartin VenturesOak HC/FT
Cambridge, US
Christophe Queva(Executive Officer)inTheodore Ashburn(Executive Officer, Director)Alon Lazarus(Director)Cameron Wheeler(Director)in
BoardBriggs Morrison(Director)inMitchell Finer(Executive Officer, Director)
Co-investorsAstellas Venture Management LLCCowen Healthcare InvestmentsDeerfield Management CompanyIMM InvestmentMPM BioImpactSphera Funds Management
BiotechWaltham, US
Chrystiyna Bedrij(Director)Peter Bisgaard(Director)Vincent Cheung(Director)Laura Benjamin(Director)Benjamin Chen(Director)
Co-investorsNan Fung Life SciencesPivotal bioVenture Partners ChinaVolcanics Venture
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.